Pharmaceutical Manufacturing Market Trends, Share, Industry Size, and Forecast By 2032

Comments · 75 Views

The global Pharmaceutical Manufacturing Market is anticipated to grow at a high CAGR of 11.4% from 2023 to 2032.

According to a new report published by K D Market Insights, titled, “Pharmaceutical Manufacturing Market Insights, Trends, Opportunity & Forecast, 2023–2032,” the global pharmaceutical manufacturing market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032.  The increasing demand for pharmaceutical products worldwide, driven by factors such as population growth, aging demographics, and the prevalence of chronic diseases., has fueled the demand for pharmaceutical manufacturing market. Advancements in technology and the rising focus on research and development activities which is the major factors augmenting the growth of the global pharmaceutical manufacturing market.

There is an increase in pharmaceutical research and development (R&D) spending. Pharmaceutical companies are investing more in R&D to discover new drugs and develop innovative treatment solutions which is further expected to create ample growth opportunities for the global pharmaceutical manufacturing market during the forecast period i.e., 2023-2032. Moreover, the growing problem of chronic disorders and the rise in the geriatric population has propelled market expansion. As the global population ages and the incidence of chronic diseases increases, there is a higher demand for pharmaceutical products to treat and manage these conditions, which is expected to contribute towards the market growth during the period.

The North America region accounted for the largest share in the global pharmaceutical manufacturing market in 2022. The region is further projected to continue dominating in the market and also register the highest CAGR in the market during the forecast period. This can be attributed to the presence of well-established pharmaceutical companies, strong healthcare infrastructure, and a favorable regulatory environment.

According to molecule type, the biologics & biosimilars (large molecules) segment accounted for the largest market share in the pharmaceutical manufacturing market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

The global pharmaceutical manufacturing market is segmented into molecule type, drug development type, formulation, routes of administration, therapy area and region. Based on molecule type, the market is bifurcated into biologics and biosimilars (large molecules), conventional drugs (small molecules). Based on, drug development type, it is classified into outsource and in-house. Based on formulation, it is classified into tablets, capsules, injectables, sprays, suspensions, powders and other formulations. Based on routes of administration, it is classified into oral, topical, parenteral, inhalations, other routes of administration. Based on therapy area, it is classified into cardiovascular diseases, pain, cancer, diabetes, respiratory diseases, and other diseases.

The global pharmaceutical manufacturing market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).

Key Insights of Light Therapy Market

  • On the basis of molecule type, the biologics & biosimilars (large molecules) segment accounted for the largest market share in the pharmaceutical manufacturing market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
  • On the basis of region, North America accounted for the largest share in the global pharmaceutical manufacturing market in 2022. The region is further projected to continue dominating in the market during the forecast period.
  • On the basis of region, Asia-Pacific is estimated to account for the second largest share in the market during the forecast period.

Some of the major pharmaceutical manufacturing companies profiled in the report include F. Hoffmann-La Roche Ltd., Novartis AG, GlaxoSmithKline plc, Pfizer, Inc., Merck & Co., Inc., AstraZeneca, Johnson & Johnson, Sanofi SA, Eli Lilly and Company, AbbVie, Inc., Sun Pharmaceutical Industries Ltd., Novo Nordisk A/S, Takeda Pharmaceuticals, Inc., Cipla Limited, Bristol Myers Squibb Company, and Gilead Sciences, Inc.

Other Trending Healthcare Market Research Reports :-

https://www.kdmarketinsights.com/reports/non-invasive-prenatal-testing-market/6850

https://www.kdmarketinsights.com/reports/breast-biopsies-market/6836

https://www.kdmarketinsights.com/reports/injection-pen-market/6834

https://www.kdmarketinsights.com/reports/topical-drug-delivery-market/6833

Comments